Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve 1. To consider & approve the un-audited Financial Results along with the Limited Review Report, for the half-year ended September 30, 2023, pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. To confirm Closure of trading window from 01st October, 2023 till the end of 48 hours after the results are made public (both days inclusive) as per the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 for Directors and Designated Employees as defined in the "Code of Conduct for Prevention of Insider Trading of the Company. 3. Any other business matter with the permission of the Chair.